Retinal Vessel Caliber and Risk Factors for Branch Retinal Vein Occlusion

2012 ◽  
Vol 37 (4) ◽  
pp. 334-338 ◽  
Author(s):  
Dong Ju Youm ◽  
Man Mook Ha ◽  
Yoosoo Chang ◽  
Su Jeong Song
Keyword(s):  
Risk Factors ◽  
Retinal Vein Occlusion ◽  
Branch Retinal Vein Occlusion ◽  
Retinal Vessel ◽  
Vein Occlusion ◽  
Retinal Vessel Caliber

Retinal Vascular Occlusive Disorders - Risk Factors

2018 ◽  
Vol 3 (02) ◽  
Author(s):  
Shivcharan Lal Chandravanshi, Sunil Kumar Shrivastava, Priyanka Agnihotri, Smriti Gupta
Keyword(s):  
Risk Factors ◽  
Retinal Vein Occlusion ◽  
Central Retinal Vein Occlusion ◽  
Branch Retinal Vein Occlusion ◽  
Retinal Artery Occlusion ◽  
Artery Occlusion ◽  
Vein Occlusion ◽  
Department Of Ophthalmology ◽  
Retinal Artery ◽  
Central Retinal Vein

Aims and Objective - The aim of the present study is to identify risk factors associated with different retinal vascular occlusive diseases (RVOD), such as central retinal artery occlusion (CRAO), hemi-retinal artery occlusion (HRAO), branch retinal artery occlusion (BRAO), cilioretinal artery occlusion (Cilio-RAO), central retinal vein occlusion (CRVO), branch retinal vein occlusion (BRVO), and hemi-retinal vein occlusion (HRVO). Patients and Method - A cross-sectional study on 114 consecutive subjects, aged 24-96 years who have attended at the outpatient department of ophthalmology at Shyam Shah Medical College, Rewa, MP, were included in the study. The Duration of study was January 2016 to December 2017. Only patients with CRAO, BRAO, HRAO, Cilio-RAO, CRVO, BRVO, and HRVO were included in the study. Other retinal vascular disorders such as diabetic vaso-occlusive disease, anterior and posterior ischemic and non-ischemic neuropathy, hypertensive retinopathy, sickle cell retinopathy, retinal telangiectasia, retinopathy of prematurity, were excluded from study. Results - We have included 114 patients, 64 cases (56.14%) males, 50 (43.85%) females, aged 56+/-8 years (range 24-96 years).  Bilateral retinal vascular occlusive disorders were seen in only 4 cases (3.5%). Two patients have bilateral CRVO followed by one case of bilateral BRVO and one case of bilateral CRAO.  Out of 114 patients, branch retinal vein occlusion was seen in 62 cases (54.38%), followed by central retinal vein occlusion in 36 cases (31.57%), CRAO in 8 cases (7.01%), and hemi- retinal vein occlusion in 4 cases (3.50%). Hypertension was the most common, (40 cases, 35.08%) risk factor identified for retinal vascular occlusive disorders followed by diabetes 24 cases (21.05%), combined diabetes and hypertension in 22 cases (19.29%), and atherosclerosis in 18 cases (15.78%). Conclusions - Retinal vascular occlusive diseases have systemic as well as ocular risk factors. Understanding of these risk factors is essential for proper treatment of RVOD. Timely identification of risk factors for RVOD may helpful in decreasing ocular and systemic morbidity in these patients.

Haemorheology in patients with branch retinal vein occlusion with and without risk factors

1996 ◽  
Vol 234 (S1) ◽  
pp. S8-S12 ◽  
Author(s):  
Andreas Remky ◽  
Oliver Arend ◽  
Friedrich Jung ◽  
Holger Kiesewetter ◽  
Martin Reim ◽  
...  
Keyword(s):  
Risk Factors ◽  
Retinal Vein Occlusion ◽  
Branch Retinal Vein Occlusion ◽  
Vein Occlusion

Branch Retinal Vein Occlusion Associated with the 20210 G-to-A Prothrombin Variant

2000 ◽  
Vol 10 (2) ◽  
pp. 177-179 ◽  
Author(s):  
C. Peris Martínez ◽  
J.A. Aviñó Martínez ◽  
M. Díaz-Llopis ◽  
E. España Gregori ◽  
J.L. Menezo ◽  
...  
Keyword(s):  
Risk Factors ◽  
Fluorescein Angiography ◽  
Medical History ◽  
Retinal Vein Occlusion ◽  
Branch Retinal Vein Occlusion ◽  
Laboratory Tests ◽  
Visual Loss ◽  
Vein Occlusion ◽  
Common Risk Factors ◽  
The Right

Purpose To describe a case of branch retinal vein occlusion (BRVO) in a patient who tested positive for the 20210 A allele of the prothrombin (PT) gene. Methods A 48-year-old man had visual loss in the right eye secondary to BRVO confirmed by ophthalmoscopy and fluorescein angiography. His medical history was not remarkable for common risk factors for retinal occlusive diseases. Results Laboratory tests for hypercoagulability were positive for PT 20210 A variant. The patient's family tested negative for the PT variant. Conclusions Laboratory tests for coagulopathy, including the PT 20210 A variant, should be added to the examination of patients with central or BRVO, especially if most common risk factors for thrombosis have been excluded.

scholarly journals New Developments in the Classification, Pathogenesis, Risk Factors, Natural History, and Treatment of Branch Retinal Vein Occlusion

2017 ◽  
Vol 2017 ◽  
pp. 1-18 ◽  
Author(s):  
Jia Li ◽  
Yannis M. Paulus ◽  
Yuanlu Shuai ◽  
Wangyi Fang ◽  
Qinghuai Liu ◽  
...  
Keyword(s):  
Risk Factors ◽  
Natural History ◽  
Retinal Vein Occlusion ◽  
Branch Retinal Vein Occlusion ◽  
New Developments ◽  
The Past ◽  
Vein Occlusion ◽  
New Ideas

For years, branch retinal vein occlusion is still a controversial disease in many aspects. An increasing amount of data is available regarding classification, pathogenesis, risk factors, natural history, and therapy of branch retinal vein occlusion. Some of the conclusions may even change our impression of branch retinal vein occlusion. It will be beneficial for our doctors to get a deeper understanding of this disease and improve the treatment skills. The aims of this review is to collect the information above and report new ideas especially from the past a few years.

Risk Factors of Branch Retinal Vein Occlusion

1985 ◽  
Vol 103 (12) ◽  
pp. 1831-1832 ◽  
Author(s):  
R. L. Johnston ◽  
A. J. Brucker ◽  
W. Steinmann ◽  
M. E. Hoffman ◽  
J. H. Holmes
Keyword(s):  
Risk Factors ◽  
Retinal Vein Occlusion ◽  
Branch Retinal Vein Occlusion ◽  
Vein Occlusion

scholarly journals Ischemia-induced spreading depolarization in the retina

2016 ◽  
Vol 36 (9) ◽  
pp. 1579-1591 ◽  
Author(s):  
Anja I Srienc ◽  
Kyle R Biesecker ◽  
Angela M Shimoda ◽  
Joanna Kur ◽  
Eric A Newman
Keyword(s):  
Retinal Vein Occlusion ◽  
Branch Retinal Vein Occlusion ◽  
Vision Loss ◽  
Nmda Antagonist ◽  
Retinal Vessel ◽  
Vessel Occlusion ◽  
Spreading Depolarization ◽  
Vein Occlusion ◽  
Retinal Vessel Occlusion

Cortical spreading depolarization is a metabolically costly phenomenon that affects the brain in both health and disease. Following severe stroke, subarachnoid hemorrhage, or traumatic brain injury, cortical spreading depolarization exacerbates tissue damage and enlarges infarct volumes. It is not known, however, whether spreading depolarization also occurs in the retina in vivo. We report now that spreading depolarization episodes are generated in the in vivo rat retina following retinal vessel occlusion produced by photothrombosis. The properties of retinal spreading depolarization are similar to those of cortical spreading depolarization. Retinal spreading depolarization waves propagate at a velocity of 3.0 ± 0.1 mm/min and are associated with a negative shift in direct current potential, a transient cessation of neuronal spiking, arteriole constriction, and a decrease in tissue O2 tension. The frequency of retinal spreading depolarization generation in vivo is reduced by administration of the NMDA antagonist MK-801 and the 5-HT(1D) agonist sumatriptan. Branch retinal vein occlusion is a leading cause of vision loss from vascular disease. Our results suggest that retinal spreading depolarization could contribute to retinal damage in acute retinal ischemia and demonstrate that pharmacological agents can reduce retinal spreading depolarization frequency after retinal vessel occlusion. Blocking retinal spreading depolarization generation may represent a therapeutic strategy for preserving vision in branch retinal vein occlusion patients.

Sign in / Sign up

Export Citation Format

Share Document